Clinical Trials · NCT00835848
Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Rigshospitalet, Denmark
- Enrollment
- 100
- Start date
- Jan 2009
- Locations
- 1 site, Denmark
- Primary endpoint
- Infarct size by MRI